FDA Issues New Safety Info on Use of Anesthesia

Share this content:
FDA Issues New Safety Info on Use of Anesthesia
FDA Issues New Safety Info on Use of Anesthesia

THURSDAY, Dec. 15, 2016 (HealthDay News) -- Repeated or lengthy use -- longer than three hours -- of general anesthetic and sedation drugs may harm the developing brains of fetuses and children younger than 3 years old, the U.S. Food and Drug Administration warned Wednesday.

After reviewing the latest published studies, the agency announced that these warnings need to be added to the labels of these drugs. The agency also issued a Drug Safety Communication to inform health care providers, parents, and caregivers of the potential danger.

"We recognize that in many cases these exposures may be medically necessary, and these new data regarding the potential harms must be carefully weighed against the risk of not performing a specific medical procedure," Janet Woodcock, M.D., director of the FDA's Center for Drug Evaluation and Research, said in a statement.

In 2010, the FDA formed a partnership with the International Anesthesia Research Society to fund research to learn more about the use of these drugs in young children and pregnant women. "We hope that this information helps enable the most informed medical decisions possible about the use of anesthesia in young children and pregnant women," Woodcock said. "We will continue to work collaboratively to leverage our collective resources to address this important issue, and we will update the public with additional information, as it becomes available."

Drug Safety Communication
More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

FDA Approves Kinase Inhibitor for Treatment of AML

FDA Approves Kinase Inhibitor for Treatment of AML

Midostaurin, in combination with chemotherapy, treats acute myeloid leukemia in adults

Enzyme Replacement Drug OK'd for Form of Batten Disease

Enzyme Replacement Drug OK'd for Form of Batten ...

Brineura will be used to treat children with late infantile neuronal ceroid lipofuscinosis type 2 Batten

is free, fast, and customized just for you!

Already a member?

Sign In Now »